ResQ Trial: Impact of an ITD and Active Compression Decompression CPR on Survival From Out-of-Hospital Cardiac Arrest
Status: | Terminated |
---|---|
Conditions: | Cardiology, Cardiology |
Therapuetic Areas: | Cardiology / Vascular Diseases |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 12/10/2017 |
Start Date: | October 2005 |
End Date: | July 2010 |
ResQ Trial: Comparison of Standard CPR Alone Versus Active Compression Decompression CPR Plus an ITD on Survival From Out-of-Hospital Cardiac Arrest
The purpose of this study is to determine whether performing active compression decompression
cardiopulmonary resuscitation (ACD-CPR) with an impedance threshold device (ITD) compared to
conventional standard cardiopulmonary resuscitation (S-CPR) will impact the neurologic
recovery and survival to hospital discharge following out-of-hospital cardiac arrest.
cardiopulmonary resuscitation (ACD-CPR) with an impedance threshold device (ITD) compared to
conventional standard cardiopulmonary resuscitation (S-CPR) will impact the neurologic
recovery and survival to hospital discharge following out-of-hospital cardiac arrest.
Despite receiving conventional, standard CPR (S-CPR), most patients who experience
out-of-hospital cardiac arrest die prior to arriving at a hospital. At the present time, the
hospital discharge rate following out-of-hospital, nontraumatic cardiac arrest in adults in
the United States is estimated to be less than 5%. Many factors contribute to the current
poor survival statistics, including the inefficiency of the technique itself. CPR provides
only 10% to 20% of normal myocardial perfusion, and only 20% to 30% of physiologically normal
cerebral perfusion.
A new method of CPR that combines ACD and an ITD (ACD-CPR+ITD) has been shown in animal
models and in clinical trials conducted in Europe to provide significantly more blood flow to
the vital organs and to improve survival rates when compared to S-CPR or ACD-CPR alone.
ACD-CPR+ITD works by decreasing intrathoracic pressure during the chest wall recoil (or
decompression) phase of CPR, creating a vacuum within the thorax relative to the rest of the
body. When compared with controls, use of ACD-CPR+ITD (a) enhances blood return to the thorax
during the chest wall recoil phase, (b) enhances blood flow to the heart and brain, (c)
provides real-time feedback to rescuers to maintain high-quality CPR, (d) improves overall
CPR efficiency and, as a result of the forgoing, (e) improves short-term survival rates.
The sponsor and others recently evaluated the effectiveness of the combination of
conventional, manual standard CPR±ITD in animals and humans. The ITD increased short-term
survival rates in these studies as well. Two clinical trials were performed in Milwaukee,
Wisconsin, under IDE (#G980125). Both compared S-CPR with either a sham (nonfunctional or
placebo) or active (functional) ITD. The results from the hemodynamic study demonstrated that
systolic blood pressure, the primary end point, increased from approximately 45 mmHg with the
sham ITD to approximately 85 mmHg with the active ITD (P less than 0.05). Intensive care unit
admission rate was the primary end point of the clinical outcome study.
Comparisons: The objective of this two-arm, multisite, randomized, pivotal IDE clinical trial
is to compare survival to hospital discharge with neurologic recovery rates in subjects
receiving S-CPR compared to ACD-CPR+ITD following out-of-hospital cardiac arrest in
well-established American emergency medical services systems.
out-of-hospital cardiac arrest die prior to arriving at a hospital. At the present time, the
hospital discharge rate following out-of-hospital, nontraumatic cardiac arrest in adults in
the United States is estimated to be less than 5%. Many factors contribute to the current
poor survival statistics, including the inefficiency of the technique itself. CPR provides
only 10% to 20% of normal myocardial perfusion, and only 20% to 30% of physiologically normal
cerebral perfusion.
A new method of CPR that combines ACD and an ITD (ACD-CPR+ITD) has been shown in animal
models and in clinical trials conducted in Europe to provide significantly more blood flow to
the vital organs and to improve survival rates when compared to S-CPR or ACD-CPR alone.
ACD-CPR+ITD works by decreasing intrathoracic pressure during the chest wall recoil (or
decompression) phase of CPR, creating a vacuum within the thorax relative to the rest of the
body. When compared with controls, use of ACD-CPR+ITD (a) enhances blood return to the thorax
during the chest wall recoil phase, (b) enhances blood flow to the heart and brain, (c)
provides real-time feedback to rescuers to maintain high-quality CPR, (d) improves overall
CPR efficiency and, as a result of the forgoing, (e) improves short-term survival rates.
The sponsor and others recently evaluated the effectiveness of the combination of
conventional, manual standard CPR±ITD in animals and humans. The ITD increased short-term
survival rates in these studies as well. Two clinical trials were performed in Milwaukee,
Wisconsin, under IDE (#G980125). Both compared S-CPR with either a sham (nonfunctional or
placebo) or active (functional) ITD. The results from the hemodynamic study demonstrated that
systolic blood pressure, the primary end point, increased from approximately 45 mmHg with the
sham ITD to approximately 85 mmHg with the active ITD (P less than 0.05). Intensive care unit
admission rate was the primary end point of the clinical outcome study.
Comparisons: The objective of this two-arm, multisite, randomized, pivotal IDE clinical trial
is to compare survival to hospital discharge with neurologic recovery rates in subjects
receiving S-CPR compared to ACD-CPR+ITD following out-of-hospital cardiac arrest in
well-established American emergency medical services systems.
Inclusion Criteria:
- Adult subjects initially presumed or known to be 18 years of age or older
- Subjects who present with out-of-hospital cardiac arrest from presumed cardiac
etiology and who receive CPR by Emergency Medical Services (EMS) personnel for at
least 1 minute
- Subjects whose airways are managed with a cuffed ET tube, combitube, or laryngeal mask
airway or facemask
Exclusion Criteria:
- Adult subjects presumed or known to be less than 18 years of age
- Subjects with known or likely traumatic injuries causing cardiac arrest or cardiac
arrest of presumed noncardiac origin
- Subjects with preexisting Do Not Resuscitate (DNR) orders
- Subjects with signs of obvious clinical death or conditions that preclude the use of
CPR
- Family or legal representative request that the subject not be entered into the study
- Subjects experiencing in-hospital cardiac arrest
- Subjects with a recent sternotomy with wound not appearing completely healed (if
unknown) or less than 6 months (if known)
- Subjects who received less than 1 minute of CPR by EMS personnel
- Subjects with a complete airway obstruction that cannot be cleared or in whom attempts
at advanced airway management are unsuccessful
- Subjects intubated with a leaky or uncuffed advanced airway device or presence of
stomas, tracheotomies, or tracheostomies
- Subjects who rearrest and are encountered by EMS within 365 days of the index cardiac
arrest
We found this trial at
7
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials